Common Stock, Shares, Outstanding of Evoke Pharma Inc from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Evoke Pharma Inc quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • Evoke Pharma Inc Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 1,722,409, a 92% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Evoke Pharma Inc Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,722,409 +827,566 +92% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 1,492,858 +758,022 +103% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 1,492,858 -7,104,547 -83% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 1,486,009 +1,207,451 +433% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 894,843 -2,448,227 -73% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 734,836 -2,608,234 -78% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 8,597,405 +5,254,335 +157% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 278,558 -3,064,512 -92% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 3,343,070 0 0% 30 Sep 2023 10-K/A 14 May 2024 2023 FY
Q2 2023 3,343,070 0 0% 30 Jun 2023 10-K/A 14 May 2024 2023 FY
Q1 2023 3,343,070 -29,574,831 -90% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 3,343,070 +621,697 +23% 31 Dec 2022 10-K/A 14 May 2024 2023 FY
Q3 2022 3,343,070 -29,313,410 -90% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 3,343,070 -29,096,310 -90% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 32,917,901 +545,947 +1.7% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 2,721,373 -23,900,581 -90% 31 Dec 2021 10-K 21 Mar 2023 2022 FY
Q3 2021 32,656,480 +6,324,358 +24% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 32,439,380 +6,428,117 +25% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 32,371,954 +7,915,040 +32% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 26,621,954 +2,190,040 +9% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 26,332,122 +2,100,208 +8.7% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 26,011,263 +1,897,307 +7.9% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 24,456,914 +6,579,381 +37% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 24,431,914 +7,004,381 +40% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 24,231,914 +6,804,381 +39% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 24,113,956 +7,215,292 +43% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 17,877,533 +2,195,053 +14% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 17,427,533 +2,013,923 +13% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 17,427,533 +2,013,923 +13% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 16,898,664 +1,510,339 +9.8% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 15,682,480 +294,155 +1.9% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 15,413,610 +3,063,250 +25% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 15,413,610 +3,063,250 +25% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 15,388,325 +8,096,484 +111% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 15,388,325 +8,152,484 +113% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 12,350,360 +5,148,586 +71% 31 Dec 2016 10-K 07 Mar 2018 2017 FY
Q3 2016 12,350,360 +5,264,856 +74% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 7,291,841 +985,711 +16% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 7,235,841 +1,036,874 +17% 31 Mar 2016 10-Q 11 May 2016 2016 Q1
Q4 2015 7,201,774 +1,089,683 +18% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 7,085,504 +973,413 +16% 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 6,306,130 +206,583 +3.4% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 6,198,967 +99,420 +1.6% 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 6,112,091 +15,339 +0.25% 31 Dec 2014 10-K 10 Mar 2016 2015 FY
Q3 2014 6,112,091 +330,339 +5.7% 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 6,099,547 30 Jun 2014 10-Q 13 Aug 2014 2014 Q2
Q1 2014 6,099,547 31 Mar 2014 10-Q 13 May 2014 2014 Q1
Q4 2013 6,096,752 +4,854,002 +391% 31 Dec 2013 10-K 04 Mar 2015 2014 FY
Q3 2013 5,781,752 30 Sep 2013 10-Q 13 Nov 2013 2013 Q3
Q4 2012 1,242,750 31 Dec 2012 10-K 25 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.